Back to Search
ELIZABETH ELLINWOOD, D.O.
D.O.
Anesthesiology Physician
NPI: 1851754246IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
05-45059(KS)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Class of 2016
Research & Publications (20)
Effects of ginseng saponin on acute cocaine-induced alterations in evoked dopamine release and uptake in rat brain nucleus accumbens.
PMID 19026615·Brain Res·2009
7-preclinical
Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine.
PMID 17651730·Eur J Pharmacol·2007
7-preclinical
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal.
PMID 17408614·Eur J Pharmacol·2007
7-preclinical
Reversal of cocaine sensitization-induced behavioral sensitization normalizes GAD67 and GABAA receptor alpha2 subunit expression, and PKC zeta activity.
PMID 17382295·Biochem Biophys Res Commun·2007
7-preclinical
Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.
PMID 16794574·Neuropsychopharmacology·2007
7-preclinical
Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression.
PMID 17056007·Biochem Biophys Res Commun·2006
7-preclinical
PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity.
PMID 16414349·Biochem Biophys Res Commun·2006
7-preclinical
Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.
PMID 15670635·Neurochem Int·2005
7-preclinical
Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration.
PMID 15496303·Eur J Pharmacol·2004
7-preclinical
The NK(1) receptor antagonist WIN51708 reduces sensitization after chronic cocaine.
PMID 15381058·Eur J Pharmacol·2004
4-observational
5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization.
PMID 12398913·Eur J Pharmacol·2002
4-observational
Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration.
PMID 12377391·Neuropsychopharmacology·2002
7-preclinical
Effect of daily dosing duration of direct and indirect dopamine receptor agonists: cocaine cross-tolerance following chronic regimens.
PMID 12208558·Eur Neuropsychopharmacol·2002
7-preclinical
Direct, real-time assessment of dopamine release autoinhibition in the rat caudate-putamen.
PMID 12074906·Neuroscience·2002
7-preclinical
Behavioral sensitization is greater after repeated versus single chronic cocaine dosing regimens.
PMID 12007922·Eur J Pharmacol·2002
7-preclinical
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.
PMID 11516769·Brain Res Brain Res Rev·2001
6-review
Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors.
PMID 11494401·Synapse·2001
4-observational
The dopamine D2/D3 antagonist DS121 potentiates the effect of cocaine on locomotion and reduces tolerance in cocaine tolerant rats.
PMID 11080548·Behav Brain Res·2000
7-preclinical
Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine.
PMID 10967364·J Neurosci Methods·2000
4-observational
Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
PMID 10771040·Eur J Pharmacol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4401 WORNALL RD
KANSAS CITY, MO 64111 - Phone
- (816) 932-2107
Quick Facts
- NPI
- 1851754246
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile